About CROMSOURCE
CROMSOURCE is a Healthcare company based in Verona (Italy) founded in 1994, and was acquired by ClinChoice in March 2023. An ISO-certified CRO and provider of outsourced services to the pharmaceutical, biotechnology and medical device industries. CROMSOURCE has completed 1 acquisition, including Pleiad. Its chief executive, as recorded, is Oriana Zerbini. CROMSOURCE offers products and services including Clinical Development, Post-Marketing Services, and Regulatory Affairs. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services.
Company details
CROMSOURCE was founded in 1994 in Verona, Italy, as an ISO-certified contract research organization. Services are offered to the pharmaceutical, biotechnology, and medical device sectors, with a focus on clinical development and staffing solutions. Operations include the management of clinical projects through Clin-Track, a GAMP5-validated modular platform that enables real-time oversight. The company supports various stages of product development in these industries.
- Headquarters Verona, Italy
- Stage Acquired
- SectorsHealthcare
- Website cromsource.com
- Social LinkedIn X YouTube
- Acquired by ClinChoice (Mar 2023)
- Latest Funding Round$1.74M (USD), Grant
Oct 2019
- InvestorsClinChoice
& 2 more
- Investments & Acquisitions
- Acquired by
Products & Services of CROMSOURCE
CROMSOURCE offers a comprehensive portfolio of products and services, including Clinical Development, Post-Marketing Services, and Regulatory Affairs.
Services for conducting clinical trials and development programs.
Support for post-approval studies and evidence generation.
Assistance with regulatory compliance and approvals.
Apps and channels of CROMSOURCE
its YouTube channel ClinChoice Inc has 38 subscribers and 9 videos.
Videos from CROMSOURCE
The most watched videos on CROMSOURCE's YouTube channel, ClinChoice Inc (38 subscribers). Click a video to play it here.
More on ClinChoice Inc.
Funding Insights of CROMSOURCE
- Total Rounds 1
- Last Round Grant — $1.74M
- First Round $1.74M
(Oct 2019)
- Investors Count 1
All 1 funding rounds of CROMSOURCE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $1.74M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in CROMSOURCE
CROMSOURCE has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include ClinChoice and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
CRO focused on data management, regulatory affairs and consulting services | 1995 | clinchoice.com | Fort Washington, United States |
Investor details for CROMSOURCE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CROMSOURCE
32 people are tracked at CROMSOURCE (14 in leadership, 18 in team).
| Name | Role | Group |
|---|---|---|
Oriana Zerbini | CEO | Leadership |
Mauro D'Apolito | Clinical Research Senior Director | Leadership |
Clara Veldman | Global Head of TalentSource Life Sciences | Leadership |
Simona Colazzo | Chief Human Resources Officer | Leadership |
Antoinette Torres Frankum | Executive Director Clinical Research Division | Leadership |
Carlo Zerbini | Chief Financial Officer | Leadership |
Troy W. McCall | Chief Commercial Officer | Leadership |
Nadia di Matteo | Legal Affairs Department Director | Leadership |
Stefano Compagni | Administrative & Group Treasury Director | Leadership |
Jenny Zecchini | Clinical Research Department Director | Leadership |
Sandra Marlow | Clinical Research Director | Leadership |
Dia Dooley | Clinical Research Department Director - North America | Leadership |
Luisa Rigon | Clinical Research Director | Leadership |
Laura Amici | Safety Unit Global Head | Leadership |
Isabelle Kinet | Senior CRA | Team |
Greta Rista | Clinical Project Manager II | Team |
Silvio Severini | MD of Techorizon | Team |
Dr. Parul Goel Patel | Clinical Data Coordinator II | Team |
Chiara Bissoli | Accounting Manager | Team |
Gina Scappucci | Senior Project Manager | Team |
12 more people are available in the full profile.
Complete people profiles for CROMSOURCE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CROMSOURCE
CROMSOURCE has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pleiad.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Limited information on core activities is available. | pleiad.com | Cambridge, United States | 1999 | Jun 2012 | •••• |
Complete acquisition details for CROMSOURCE
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of CROMSOURCE
4 dated milestones of CROMSOURCE across 29 years, from founding to its latest funding, stage changes and deals.
- Founded CROMSOURCE is founded.
- Acquisition Acquires Pleiad.
- Funding First funding round of $1.7M.
- Exit Acquired by ClinChoice.
Web traffic of CROMSOURCE
Websites that share an audience with CROMSOURCE (cromsource.com).
Websites whose visitors overlap most with CROMSOURCE. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmatching.com | 100% | View details | |||
| clintec.com | 98% | View details | |||
| pharmaceutical-business-review.com | 98% | #2,626,966 | View details | ||
| appliedclinicaltrialsonline.com | 98% | #747,616 | View details | ||
| centerwatch.com | 98% | 158.2K | #254,725 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for CROMSOURCE
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cromsource
Complete news archive for CROMSOURCE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CROMSOURCE
CROMSOURCE was founded in 1994 and raised its 1st funding round 25 years after it was founded.
CROMSOURCE is headquartered in Verona, Italy. It is registered at Verona, Veneto, Italy.
Oriana Zerbini is the CEO of CROMSOURCE, as recorded in our data.
CROMSOURCE was founded in 1994 in Verona, Italy, as an ISO-certified contract research organization. Services are offered to the pharmaceutical, biotechnology, and medical device sectors, with a focus on clinical development and staffing solutions. Operations include the management of clinical projects through Clin-Track, a GAMP5-validated modular platform that enables real-time oversight. The company supports various stages of product development in these industries.
CROMSOURCE offers Clinical Development, Post-Marketing Services, and Regulatory Affairs.
CROMSOURCE has made 1 acquisition, including Pleiad.
CROMSOURCE has 2 investors. Key investors include ClinChoice, and European Union.
Yes. CROMSOURCE was acquired by ClinChoice in March 2023.